NCT06086483View on ClinicalTrials.gov

Pain Management After Adductor Canal Block for Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

July 20, 2022

Study Completion Date

August 24, 2023

Conditions
Knee OsteoarthritisKnee ArthritisKnee ArthropathyKnee Pain Chronic
Interventions
DRUG

Ropivacaine 0.2% Injectable Solution

"20 mL 0.5% ropivacaine was injected into the PENG block~20 mL 0.5% ropivacaine was injected into the Adductor Canal block"

DRUG

0.9%sodium chloride

"20 mL 0.9% sodium chloride was injected into the PENG block~20 mL 0.5% sodium chloride was injected into the Adductor Canal block"

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06086483 - Pain Management After Adductor Canal Block for Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter